FDA-mandated ocular assessments are derailing timelines, including phase 2/3 MDD, Bipolar, and Epilepsy trials. We fix the ocular endpoint risk—fast.
Trusted by these leading partners.
No obligation. Fast response. Zero spam.
Get a Trial Rescue Plan
We are the industry experts in deploying certified, point-of-need ophthalmic teams to rescue studies.
40+ Clinical Trials Stabilized
48 StatesNationwide Coverage
85,000+Eye Assessments Administered
Time is critical. Schedule time now to protect your endpoints and regain timeline control.
"While working with 20/20 Onsite for previous and current studies, we have been able to provide ophthalmological services that were previously not feasible for our clinical units. Doing so has been very successful in providing safety and ophthalmological oversight of study participants – as required by good clinical practices and the sponsor protocol."
- Dr. David Wyatt, Vice-President and Global Medical Lead, Syneos Health
Trusted by leading sponsors, CROs, and sites
Point of Need
100%
Screening timelines met across all business operations.
